[go: up one dir, main page]

MX2011012732A - Composicion estabilizada que comprende por lo menos un compuesto adrenergico. - Google Patents

Composicion estabilizada que comprende por lo menos un compuesto adrenergico.

Info

Publication number
MX2011012732A
MX2011012732A MX2011012732A MX2011012732A MX2011012732A MX 2011012732 A MX2011012732 A MX 2011012732A MX 2011012732 A MX2011012732 A MX 2011012732A MX 2011012732 A MX2011012732 A MX 2011012732A MX 2011012732 A MX2011012732 A MX 2011012732A
Authority
MX
Mexico
Prior art keywords
adrenergic compound
stabilised composition
compound
stabilised
composition
Prior art date
Application number
MX2011012732A
Other languages
English (en)
Inventor
Alan J Baillie
Kenneth Macdonald
Pamela Porteous
Simon Hendry
Original Assignee
Alk Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alk Ag filed Critical Alk Ag
Publication of MX2011012732A publication Critical patent/MX2011012732A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Una composición estabilizada que comprende por lo menos un compuesto adrenérgico y por lo menos un antioxidante seleccionado del grupo que consiste de un bisulfito, un metabisulfito y un compuesto de sulfito.
MX2011012732A 2009-06-04 2010-06-03 Composicion estabilizada que comprende por lo menos un compuesto adrenergico. MX2011012732A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18406609P 2009-06-04 2009-06-04
DKPA200900705 2009-06-04
PCT/EP2010/057771 WO2010139751A2 (en) 2009-06-04 2010-06-03 Stabilised composition comprising at least one adrenergic compound

Publications (1)

Publication Number Publication Date
MX2011012732A true MX2011012732A (es) 2012-02-28

Family

ID=41364279

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2011012732A MX2011012732A (es) 2009-06-04 2010-06-03 Composicion estabilizada que comprende por lo menos un compuesto adrenergico.
MX2011012735A MX2011012735A (es) 2009-06-04 2010-06-03 Composicion estabilizada que comprende por lo menos un compuesto adrenergico.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2011012735A MX2011012735A (es) 2009-06-04 2010-06-03 Composicion estabilizada que comprende por lo menos un compuesto adrenergico.

Country Status (15)

Country Link
US (1) US9155694B2 (es)
EP (2) EP2437781B1 (es)
JP (2) JP2012528830A (es)
KR (2) KR20120044309A (es)
CN (3) CN106109397A (es)
AU (2) AU2010255747B2 (es)
BR (2) BRPI1013019A2 (es)
CA (2) CA2764050C (es)
DK (2) DK2437781T3 (es)
ES (2) ES2432241T3 (es)
MX (2) MX2011012732A (es)
PT (2) PT2437781E (es)
RU (2) RU2527680C2 (es)
SI (2) SI2437781T1 (es)
WO (2) WO2010139752A2 (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8628805B2 (en) * 2009-06-04 2014-01-14 Alk Ag Stabilized composition comprising at least one adrenergic compound
CN102525893B (zh) * 2012-01-04 2013-11-20 上海禾丰制药有限公司 盐酸去氧肾上腺素注射液及其制剂工艺
CN102525894A (zh) * 2012-01-04 2012-07-04 上海禾丰制药有限公司 盐酸异丙肾上腺素注射液及其制剂工艺
CN104703587A (zh) * 2012-10-08 2015-06-10 沃克哈特有限公司 肾上腺素及其盐的稳定的可注射药物组合物
TWI641381B (zh) * 2013-02-04 2018-11-21 法商賽諾菲公司 胰島素類似物及／或胰島素衍生物之穩定化醫藥調配物
US12239822B2 (en) 2013-03-15 2025-03-04 Windgap Medical, Inc. Portable drug mixing and delivery device and associated methods
KR20160070077A (ko) 2013-10-03 2016-06-17 임프리미스 파마슈티컬스 인코포레이티드 안구내 투여를 위한 에피네프린-기반 안과용 조성물 및 이의 제조 방법
CN103520096B (zh) * 2013-10-25 2015-02-25 成都晶博生物科技有限责任公司 一种硫酸特布他林注射液的生产工艺
JP2017503017A (ja) 2013-12-18 2017-01-26 ウィンドギャップ メディカル， インコーポレイテッド 薬物混合および送達システムならびに方法
EP3091995B1 (en) 2014-01-09 2024-03-20 Sanofi Stabilized pharmaceutical formulations of insulin aspart
UY35988A (es) 2014-02-27 2015-09-30 Sint Sa Proceso para la producción de una solución inyectable de noradrenalina de baja concentración
EP2990031B1 (en) * 2014-08-28 2019-11-13 Sun Pharmaceutical Industries Ltd Parenteral dosage form of norepinephrine
HK1244450A1 (zh) * 2014-12-18 2018-08-10 温德加普医疗股份有限公司 用於溶解或增溶治疗剂的方法和组合物
US20170189352A1 (en) 2015-03-13 2017-07-06 Par Pharmaceutical, Inc. Epinephrine formulations
US9119876B1 (en) * 2015-03-13 2015-09-01 Par Pharmaceutical, Inc. Epinephrine formulations
US11517525B2 (en) * 2015-09-18 2022-12-06 Hikma Pharmaceuticals Usa Inc. Epinephrine spray formulations
US10039710B2 (en) * 2015-09-18 2018-08-07 Insys Development Company, Inc. Epinephrine spray formulations
EP3503873A4 (en) * 2016-08-25 2020-04-15 Harrow IP, LLC EPINEPHRINE-BASED OPHTHALMIC COMPOSITIONS FOR INTRAOCULAR ADMINISTRATION AND METHOD FOR THE PRODUCTION THEREOF
RU2635759C1 (ru) * 2016-09-13 2017-11-15 Интеллег Сосьете Анониме Фармацевтическая композиция для парентерального введения и способ ее получения
US10835503B2 (en) * 2017-01-13 2020-11-17 Teva Pharmaceuticals Usa, Inc. Pre-filled syringe
US20250177328A1 (en) 2017-01-30 2025-06-05 Nevakar Injectables Inc. Norepinephrine compositions and methods therefor
WO2018140894A1 (en) 2017-01-30 2018-08-02 Nevakar, Inc Norepinephrine compositions and methods therefor
JOP20190241B1 (ar) * 2017-04-17 2023-09-17 Hikma Pharmaceuticals Usa Inc مستحضرات رذاذ إبينيفرين
EP3687475A4 (en) * 2017-09-26 2021-07-28 YS Pharmtech STABILIZATION OF EPINEPHRIN FORMULATIONS
BR112020006950A2 (pt) 2017-10-10 2020-10-06 Merck Patent Gmbh composições farmacêuticas injetáveis estabilizadas de l-epinefrina
WO2019182745A1 (en) 2018-03-19 2019-09-26 Bryn Pharma, LLC Epinephrine spray formulations
CA3093725C (en) 2018-03-23 2021-08-24 Nevakar Inc. Epinephrine compositions and containers
US10952962B1 (en) 2018-04-11 2021-03-23 QuVa Pharma, Inc. Ready to use liquid formulation
EP3773479A1 (en) 2018-04-11 2021-02-17 Quva Pharma, Inc. Ready to use liquid reck formulation
US10478406B2 (en) 2019-03-18 2019-11-19 HARC Therapeutics AG High-pH solid-state epinephrine formulation
CN112138250B (zh) * 2019-06-28 2023-04-14 四川普锐特药业有限公司 保持给药均一度的药物流体分配器及右美托咪定鼻喷器
CN114286669A (zh) * 2019-08-08 2022-04-05 太阳医药工业有限公司 去甲肾上腺素的输注剂型
USD1004518S1 (en) 2019-09-09 2023-11-14 Brunswick Corporation Railing for a marine vessel
CA3174640A1 (en) * 2020-03-06 2021-09-10 Baxter International Inc. Packaged, sealed container system for stable storage of an oxygen sensitive pharmaceutical formulation
USD984953S1 (en) 2021-05-03 2023-05-02 Brunswick Corporation Safely railing having buoy holder
AU2021203856B2 (en) * 2021-06-10 2023-03-09 Animal Ethics Pty Ltd Topical anaesthetic composition having improved vasoconstrictor stability
AU2023332633A1 (en) * 2022-08-27 2025-04-03 Biophore India Pharmaceuticals Pvt. Ltd Trientine liquid dosage forms

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB425678A (en) 1933-06-15 1935-03-15 Novocol Chemical Mfg Co Inc Improvements relating to anesthetics for hypodermic injection
US2047144A (en) * 1934-03-26 1936-07-07 Lilly Co Eli Stabilized epinephrine-type compound, and process of stabilizing it
US2382546A (en) * 1941-11-03 1945-08-14 Curtis David Anesthetic solutions
BE617022A (es) * 1961-04-28
US3419035A (en) * 1965-05-25 1968-12-31 Badger Meter Mfg Co Air elimination device for liquid transport system
CA981182A (en) 1972-01-07 1976-01-06 Walter A. Borisenok Stabilization of 1-epinephrine in local anesthetic solutions with a combination of three antioxidants
US3966905A (en) * 1973-05-29 1976-06-29 Barnes-Hind Pharmaceuticals, Inc. Stabilized catechol amine solutions
DD150694A1 (de) 1980-04-16 1981-09-16 Gisela Raether Verfahren zur stabilisierung von pharmazeutischen praeparaten mit oxidationsempfindlichen bestandteilen
US4734438A (en) 1983-04-26 1988-03-29 Macri Frank J Norepinephrine potentiated compositions and method of use
WO1994013274A1 (en) 1992-12-10 1994-06-23 Abbott Laboratories Stabilized catecholamine solutions
JP3535537B2 (ja) * 1993-04-15 2004-06-07 日本製薬株式会社 静脈注射剤
US6077545A (en) 1995-10-30 2000-06-20 Matrix Pharmaceuticals, Inc. Process and composition for therapeutic cisplatin (CDDP)
JP2001505197A (ja) 1996-11-14 2001-04-17 アルザ・コーポレーション リドカイン及びエピネフリンの電気的補助投与のための製剤
DE69824277T2 (de) * 1997-07-11 2004-09-23 Toray Industries, Inc. Stabile medizinische zusammenstellungen die 4,5-epoxymorphinanderivate enthalten
JP4393641B2 (ja) 1998-11-26 2010-01-06 久光製薬株式会社 イオントフォレーシス用粘着ゲル組成物及びその装置
WO2002026223A2 (en) 2000-09-29 2002-04-04 Board Of Trustees Operating Michigan State University Catecholamine pharmaceutical compositions and methods
EP1698640B2 (en) * 2003-10-01 2019-06-19 Kyowa Hakko Kirin Co., Ltd. Method of stabilizing antibody and stabilized solution-type antibody preparation
UA71839C2 (uk) * 2003-12-30 2007-06-25 Товариство З Обмеженою Відповідальністю "Фарм-Стом" Фармацевтична композиція на основі артикаїну та епінефрину
US20050228336A1 (en) 2004-04-07 2005-10-13 Preston Keusch Electrically assisted lidocaine and epinephrine delivery device having extended shelf-stability
US20060129122A1 (en) 2004-12-06 2006-06-15 Wyrick Ronald E Method and apparatus for delivering epinephrine
DK2010220T3 (da) * 2006-04-03 2022-05-23 Ceva Animal Health Pty Ltd Stabiliserede pentosanpolysulfat-(pps)-formuleringer
US20070249727A1 (en) * 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
US20080269347A1 (en) * 2006-09-28 2008-10-30 Azopharma, Inc. Epinephrine formulations
US8628805B2 (en) 2009-06-04 2014-01-14 Alk Ag Stabilized composition comprising at least one adrenergic compound

Also Published As

Publication number Publication date
EP2437782B1 (en) 2013-07-24
AU2010255747A1 (en) 2012-02-02
US9155694B2 (en) 2015-10-13
EP2437781B1 (en) 2013-07-24
RU2527337C2 (ru) 2014-08-27
US20120129944A1 (en) 2012-05-24
AU2010255748A1 (en) 2011-12-08
RU2011153403A (ru) 2013-07-20
ES2432241T3 (es) 2013-12-02
JP6087145B2 (ja) 2017-03-01
KR20120044309A (ko) 2012-05-07
WO2010139751A3 (en) 2011-04-07
CA2764051A1 (en) 2010-12-09
CN106109397A (zh) 2016-11-16
AU2010255747B2 (en) 2014-03-13
WO2010139752A2 (en) 2010-12-09
CA2764050A1 (en) 2010-12-09
PT2437782E (pt) 2013-10-30
PT2437781E (pt) 2013-10-30
RU2011153410A (ru) 2013-07-20
BRPI1013019A2 (pt) 2016-03-29
CN102497882A (zh) 2012-06-13
MX2011012735A (es) 2012-02-28
EP2437781A2 (en) 2012-04-11
SI2437782T1 (sl) 2013-12-31
RU2527680C2 (ru) 2014-09-10
RU2527337C9 (ru) 2014-12-27
KR20120028344A (ko) 2012-03-22
ES2432164T3 (es) 2013-12-02
WO2010139752A3 (en) 2011-04-07
AU2010255748B2 (en) 2014-03-13
BRPI1011074A2 (pt) 2016-04-12
CA2764050C (en) 2017-02-28
SI2437781T1 (sl) 2013-12-31
DK2437782T3 (da) 2013-10-28
WO2010139751A2 (en) 2010-12-09
JP2012528831A (ja) 2012-11-15
DK2437781T3 (da) 2013-10-21
CN102802668A (zh) 2012-11-28
JP2012528830A (ja) 2012-11-15
EP2437782A2 (en) 2012-04-11

Similar Documents

Publication Publication Date Title
MX2011012735A (es) Composicion estabilizada que comprende por lo menos un compuesto adrenergico.
UA107791C2 (en) Pesticidal compositions
PH12017502300A1 (en) Pesticidal compositions and processes related thereto
EP2325175A4 (en) 2,4-DIAMINOPYRIMIDINVERBINDUNG
MX2013005065A (es) Composiciones pesticidas y procesos relacionados.
EA200801959A1 (ru) Высокоразветвленный полипропилен
TR201907828T4 (tr) Geni̇ş spektrumlu bi̇r anti̇-mi̇krobi̇yel ajan
CO6241120A2 (es) (DIHIDRO)PIRROLO[2,1-á]ISOQUINOLINAS.
BRPI0914940A8 (pt) Composições nutritivas contendo punicalaginas
PH12013500076A1 (en) Cellulosic material
ECSP10010491A (es) Composiciones fungicidas con 3'-bromo-2,3,4,6'-tetrametoxi-2',6-dimetilbenzofenona
CL2008002704A1 (es) Composicion herbicida que comprende un compuesto derivado de 1,4-dihidro-2h-piridazin-3-ona.
SG163478A1 (en) Polymer stabilizer
PH12013500285A1 (en) Composition for preventing/controlling harmful arthropods and method for preventing/controlling harmful arthropods
UA37264U (en) Coordination compound of europium (iii) thenoyltrifluoroacetylacetonate with azeloylbis(3,5-dimethylpyrazol)
AU318769S (en) Kayak
UA43771U (ru) 5-r-4-r1-1,2,4-триазол-3-тионы, которые имеют антиоксидантную активность
UA29550U (en) Compound 1-(1',1'-difluoro-2'-bromo-2'-chloroethyl)-5-bromouracil with potential physiological properties
AU311604S (en) Sink
UA36194U (en) Use of quercetin as hepatoprotector
GR1005892B (el) Νεο θερμοκηπιο.
UA78894U (en) Nanostructure
AU315964S (en) A stiffener
UA34276U (ru) 7-β-ГИДРОКСИЭТИЛ-3-МЕТИЛ-8-N-ПИРРОЛИДИНОКСАНТИН, КОТОРЫЙ ПРОЯВЛЯЕТ ДИУРЕТИЧЕСКОЕ ДЕЙСТВИЕ
UA35938U (en) 1-phenyl-o-tolylamino-1,5-dihydropyrrol-2-one having antioxidant activity

Legal Events

Date Code Title Description
FG Grant or registration